IBCL - 141
Golcadomide, a Potential First-in-Class, Oral Celmod ± Rituximab in the Phase 1/2 CC-99282-NHL-001 Study: Long-Term Follow-Up Results of Patients With Relapsed/Refractory Follicular Lymphoma
Javier Munoz
Poster Presenter: Javier Munoz
1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
SOHO 2026 Annual Meeting
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
Authors
Showing 3 results for author "Javier Munoz".
MCL - 1296
Treatment Patterns and Clinical Outcomes Among Patients With Treatment-Naïve and Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) in Community Practice Between 2020 and 2025
Javier Munoz
Poster Presenter: Javier Munoz
MCL - 178
Clinical Outcomes Among Patients With Relapsed/Refractory Mantle Cell Lymphoma Receiving Zanubrutinib or Acalabrutinib in Real-World Practice in the United States
Javier Munoz
Poster Presenter: Javier Munoz